These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 9921795)

  • 1. Unbound cyclosporine and allograft rejection after heart transplantation.
    Akhlaghi F; Keogh AM; Brown KF
    Transplantation; 1999 Jan; 67(1):54-9. PubMed ID: 9921795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclosporine plasma unbound fraction in heart and lung transplantation recipients.
    Akhlaghi F; Ashley J; Keogh A; Brown K
    Ther Drug Monit; 1999 Feb; 21(1):8-16. PubMed ID: 10051049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of HLA mismatching and immunosuppressive therapy on early rejection outcome in pediatric heart transplant recipients.
    Herzberg GZ; Rossi AF; Courtney M; Gelb BD
    J Heart Lung Transplant; 1998 Dec; 17(12):1195-200. PubMed ID: 9883760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utility of surveillance biopsies in infant heart transplant recipients.
    Balzer DT; Moorhead S; Saffitz JE; Huddleston CB; Spray TL; Canter CE
    J Heart Lung Transplant; 1995; 14(6 Pt 1):1095-101. PubMed ID: 8719456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety, tolerability and efficacy of cyclosporine microemulsion in heart transplant recipients: a randomized, multicenter, double-blind comparison with the oil based formulation of cyclosporine--results at six months after transplantation.
    Eisen HJ; Hobbs RE; Davis SF; Laufer G; Mancini DM; Renlund DG; Valantine H; Ventura H; Vachiery JL; Bourge RC; Canver CC; Carrier M; Costanzo MR; Copeland J; Dureau G; Frazier OH; Dorent R; Hauptman PJ; Kells C; Master R; Michaud JL; Paradis I; Smith A; Vanhaecke J; Mueller EA
    Transplantation; 1999 Sep; 68(5):663-71. PubMed ID: 10507486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adult heart transplantation under tacrolimus (FK506) immunosuppression: histopathologic observations and comparison to a cyclosporine-based regimen with lympholytic (ATG) induction.
    Tsamandas AC; Pham SM; Seaberg EC; Pappo O; Kormos RL; Kawai A; Griffith BP; Zeevi A; Duquesnoy R; Fung JJ; Starzl TE; Demetris AJ
    J Heart Lung Transplant; 1997 Jul; 16(7):723-34. PubMed ID: 9257254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of routine mycophenolate mofetil drug monitoring on the treatment of cardiac allograft rejection.
    Yamani MH; Starling RC; Goormastic M; Van Lente F; Smedira N; McCarthy P; Young JB
    Transplantation; 2000 Jun; 69(11):2326-30. PubMed ID: 10868634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural history of focal moderate cardiac allograft rejection. Is treatment warranted?
    Winters GL; Loh E; Schoen FJ
    Circulation; 1995 Apr; 91(7):1975-80. PubMed ID: 7895355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac allograft rejection: do trough cyclosporine levels correlate with the grade of histologic rejection?
    el Gamel A; Keevil B; Rahman A; Campbell C; Deiraniya A; Yonan N
    J Heart Lung Transplant; 1997 Mar; 16(3):268-74. PubMed ID: 9087869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Blood levels of cyclosporine, acute rejections and the prognosis of the allografts in pediatric renal allograft recipients].
    Sakuma T; Ogawa O; Kawamura T; Hasegawa A; Kamidono S
    Nihon Hinyokika Gakkai Zasshi; 1995 Sep; 86(9):1450-9. PubMed ID: 7474634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heart allograft rejection under varying immunosuppressive protocols as evaluated by endomyocardial biopsy.
    Imakita M; Tazelaar HD; Billingham ME
    J Heart Transplant; 1986; 5(4):279-85. PubMed ID: 3305819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of clinical outcomes after tacrolimus conversion for resistant kidney rejection or cyclosporine toxicity with pathologic staging by the Banff criteria.
    Morrissey PE; Gohh R; Shaffer D; Crosson A; Madras PN; Sahyoun AI; Monaco AP
    Transplantation; 1997 Mar; 63(6):845-8. PubMed ID: 9089224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Failure to down-regulate intragraft cytokine mRNA expression shortly after clinical heart transplantation is associated with high incidence of acute rejection.
    de Groot-Kruseman HA; Baan CC; Loonen EH; Mol WM; Niesters HG; Maat AP; Balk AH; Weimar W
    J Heart Lung Transplant; 2001 May; 20(5):503-10. PubMed ID: 11343976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Quantification of cell proliferation with the proliferation marker MIB-1 in endomyocardial biopsies after heart transplantation. An aid in diagnosis of graft rejection needing treatment?].
    Gerbaulet S; Sigmund M; Hauptmann S; Janssens U
    Z Kardiol; 1998 Aug; 87(8):613-21. PubMed ID: 9782594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early cyclosporine blood levels impact the incidence of acute rejection and overall mortality in the first year after heart transplantation.
    Gómez-Sánchez MA; Delgado JF; Escribano P; Santos M; Sotelo T; Gil R; Hernández-Afonso J; Ortuño B; Romero F; Sáenz de la Calzada C; Rodriguez JE; Rufilanchas JJ
    Transplant Proc; 1998 Aug; 30(5):1671-2. PubMed ID: 9723237
    [No Abstract]   [Full Text] [Related]  

  • 16. Induction therapy after cardiac transplantation: a comparison of anti-thymocyte globulin and daclizumab in the prevention of acute rejection.
    Carlsen J; Johansen M; Boesgaard S; Andersen CB; Arendrup H; Aldershvilet J; Mortensen SA
    J Heart Lung Transplant; 2005 Mar; 24(3):296-302. PubMed ID: 15737756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute rejection: significance of elapsed time after transplantation.
    Rizeq MN; Masek MA; Billingham ME
    J Heart Lung Transplant; 1994; 13(5):862-8. PubMed ID: 7803428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelin plasma levels in acute graft rejection after heart transplantation.
    Dengler TJ; Zimmermann R; Tiefenbacher CP; Braun K; Sack FU; Kübler W
    J Heart Lung Transplant; 1995; 14(6 Pt 1):1057-64. PubMed ID: 8719451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral steroid pulse without taper for the treatment of asymptomatic moderate cardiac allograft rejection.
    Park MH; Starling RC; Ratliff NB; McCarthy PM; Smedira NS; Pelegrin D; Young JB
    J Heart Lung Transplant; 1999 Dec; 18(12):1224-7. PubMed ID: 10612382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multicenter randomized trial comparing tacrolimus (FK506) and cyclosporine in the prevention of renal allograft rejection: a report of the European Tacrolimus Multicenter Renal Study Group.
    Mayer AD; Dmitrewski J; Squifflet JP; Besse T; Grabensee B; Klein B; Eigler FW; Heemann U; Pichlmayr R; Behrend M; Vanrenterghem Y; Donck J; van Hooff J; Christiaans M; Morales JM; Andres A; Johnson RW; Short C; Buchholz B; Rehmert N; Land W; Schleibner S; Forsythe JL; Talbot D; Pohanka E
    Transplantation; 1997 Aug; 64(3):436-43. PubMed ID: 9275110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.